Evidence map›Paper›PMID 39375841›Full record

ReviewExpert reviews in molecular medicine2024

Advances in Raman spectroscopy for characterising oral cancer and oral potentially malignant disorders.

Katie Hanna, Anna-Lena Asiedu, Thomas Theurer, David Muirhead, Valerie Speirs, Yara Oweis, Rasha Abu-Eid

Abstract readReview
In one paragraph

Review in Expert reviews in molecular medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Katie HannaSchool of Medicine, Medical Sciences and Nutrition, University of Aberdeen, Scotland, UK.ORCID 0000-0001-8348-2399
Anna-Lena AsieduSchool of Medicine, Medical Sciences and Nutrition, University of Aberdeen, Scotland, UK.
Thomas TheurerSchool of Geoscience, University of Aberdeen, Aberdeen, Scotland, UK.ORCID 0000-0002-3508-8116
David MuirheadSchool of Geoscience, University of Aberdeen, Aberdeen, Scotland, UK.ORCID 0000-0003-2065-6042
Valerie SpeirsSchool of Medicine, Medical Sciences and Nutrition, University of Aberdeen, Scotland, UK.ORCID 0000-0002-0602-4666
Yara OweisSchool of Dentistry, University of Jordan, Amman, Jordan.ORCID 0000-0003-0836-6309
Rasha Abu-EidSchool of Medicine, Medical Sciences and Nutrition, University of Aberdeen, Scotland, UK.ORCID 0000-0002-6634-0329

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Oral cancer survival rates have seen little improvement over the past few decades. This is mainly due to late detection and a lack of reliable markers to predict disease progression in oral potentially malignant disorders (OPMDs). There is a need for highly specific and sensitive screening tools to enable early detection of malignant transformation. Biochemical alterations to tissues occur as an early response to pathological processes; manifesting as modifications to molecular structure, concentration or conformation. Raman spectroscopy is a powerful analytical technique that can probe these biochemical changes and can be exploited for the generation of novel disease-specific biomarkers. Therefore, Raman spectroscopy has the potential as an adjunct tool that can assist in the early diagnosis of oral cancer and the detection of disease progression in OPMDs. This review describes the use of Raman spectroscopy for the diagnosis of oral cancer and OPMDs based on ex vivo and liquid biopsies as well as in vivo applications that show the potential of this powerful tool to progress from benchtop to chairside.

Indexed as

Mouth NeoplasmsSpectrum Analysis, RamanAnimalsBiomarkers, TumorEarly Detection of CancerHumansPrecancerous ConditionsBiomarkers, Tumordetectiondiagnosisoral canceroral potentially malignant disordersRaman spectroscopy

Identifiers

PMID39375841
PMCPMC11488342

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.